Copay assistance programs play an essential role for patients who receive treatment for retinal diseases. The underfunding of one such program, Good Days, has led to significant treatment disruptions, especially in low-income areas, according to two separate presentations at the American Society of Retina Specialists (ASRS) annual meeting being held in Long Beach, California.

For more than 20 years, Good Days , a nonprofit organization, has provided copay and financial assistance for patients facing financial challenges related to healthcare. But as of January 2025, funding for retina and macular disease treatment has been unreliable as costs have increased.

As a result of funding for copay and coinsurance, patients with wet age-related macular degeneration, diabetic macular edema and

See Full Page